Lifeboat Foundation

The digital transformation of society has brought many immediate benefits: it’s created new jobs and services, boosted efficiency and promoted innovation. But when it comes to improving the way we govern, the story is not that simple.

It seems reasonable to imagine introducing digital information and communication technologies into public sector organisations – known as “digital government” or “e-government” – would have a beneficial impact on the way public services are delivered. For instance, by enabling people to claim rebates for medical bills via a government website.

When implemented well, e-government can reduce the cost of delivering government and public services, and ensure better contact with citizens – especially in remote or less densely populated areas. It can also contribute to greater transparency and accountability in public decisions, stimulate the emergence of local e-cultures, and strengthen democracy.

Here in beautiful Basel, Switzerland we open the section Aging and Drug Discovery, actually an intersection of AI, longevity and drug discovery in the Innovation Forums of Basel Life Conference 2018. Dr Alex Zhavoronkov (InSilico Medicine) and Dr Morten Scheibye-Knudsen (University Copenhagen) welcomed us. Dr Jay Olshansky (University of Illinois at Chicago) gave the first lecture. Some examples for age face recognition were shown, emphasising the importance of wrinkles from smoking or others and suggesting that looking younger means living longer! After the wonderful lecture I immediately went to correct my make-up!

Β-hydroxybutyrate seems to prevent senescence of vascular tissue.

According to a study by Georgia State University scientists, a molecule called β-hydroxybutyrate has anti-aging effects on the vascular system; more specifically, the molecule appears to prevent senescence of vascular cells by promoting cellular quiescence instead [1].

Study abstract

Continue reading “Molecule Appears to Have Anti-Aging Effects on the Vascular System” »

Utilizing new mobile application technology, researchers at The University of New Mexico found that medical cannabis provides immediate symptom relief across dozens of health symptoms with relatively minimal negative side effects.

In two recent studies titled, “Patient-Reported Symptom Relief Following Medical Cannabis Consumption,” and “Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions” published in the journals, Frontiers in Pharmacology and Medicines, respectively, UNM Department of Psychology Associate Professor Jacob Miguel Vigil and UNM Department of Economics Assistant Professor Sarah See Stith, document that patients experienced statistically and clinically significant therapeutic benefits when they used cannabis for symptoms ranging from chronic pain to insomnia.

These studies analyzed data collected with the Releaf App, developed by co-authors Franco Brockelman, Keenan Keeling and Branden Hall and currently, the largest repository of user-entered information on the consumption and effects of cannabis use in the United States with nearly 100,000 recorded user sessions.

Continue reading “Study shows medical cannabis effective in treating a wide range of health conditions” »

https://paper.li/e-1437691924#/

Descartes once described the human body as a “fleshy machine” and today’s transhumanists would likely agree.

Philosopher Nick Bostrom writes that as we seek to peer farther into posthumanity our ability to concretely imagine what it might be like trails offend that the very essence of posthumanity is to be able to have thoughts and experiences that we cannot readily think or experience with our current capacities.

Continue reading “The Augmented Posthuman Body” »

The German start-up company ELiSE creates the DNA of a technical part. Based on the DNA, automated design processes are used to find the best solution which considers all predefined constraints and which is produced by additive manufacturing. Meet ELiSE at ESA’s Start-ups Zone powered by ESA space solutions at IAC 2018.

Happy to announce our support for Elevian together with BOLD Capital and Peter Diamandis.

Commercializing scientific breakthroughs from Elevian’s scientific co-founders.

Continue reading “Elevian Launches to Develop Regenerative Medicines for Age-Related Diseases” »

I don’t remember what it feels like to live without pain. At 15, I began feeling aching, stabbing, and burning sensations in my lower back and down my legs. Swallowing a few Aleve didn’t help—in fact, nothing did. If I sit or stand for any period of time, or lift something heavy or fall, I pay for it, sometimes for weeks or months. I’ve slept on the kitchen linoleum, because the carpet felt too soft to stand.

For 17 years, I went to doctor after doctor, undergoing scans, physical therapy, and just about every “alternative” treatment that promised relief. Despite some amazing doctors and the expensive tests at their disposal, they could never see anything wrong, so I never got a diagnosis.

That is, until a couple of years ago, when a routine CAT scan finally caught a structural problem with my spine. Because of that, I qualified to have a spinal cord stimulator, an electronic device used to treat chronic pain, implanted into my back. Although I was scared to go under the knife, I was more than willing to become a cyborg in order to find even partial relief. And this type of therapy might also be able to help some of the 100 million Americans who suffer from chronic pain.

Researchers don’t know much about whether people who aren’t diabetic should avoid having glucose spikes after meals, or whether, by contrast, average glucose levels are more important — things that need to be studied, he said.

“They’re right to be asking it. I don’t have data to give guidance on how to interpret it,” Bergenstal said. “I think they’re right to say it can’t be bad if I keep my blood sugars more stable. It’s a reasonable assumption, but we don’t have the data for it.”

It’s generally accepted that non-diabetics are better able to regulate their glucose levels. A higher than normal level, meanwhile, indicates prediabetes. But a new study out of Stanford University in late July that used CGMs on 57 participants, including diabetics and non-diabetics, had a surprising finding.

Continue reading “Non-diabetics are using diabetes technology to track their blood sugar and improve their health” »